| abstract |
The present disclosure, relates, in general to a recombinant herpesvirus construct comprising nearly a full length genome of an immunodeficiency virus, e.g., human immunodeficiency virus (HIV), useful as a vaccine to treat or prevent infection of other immunodeficiency viruses, such as simian, bovine or feline immunodeficiency virus. |